Back

Scoring Physician Risk Communication in Prostate Cancer Using Large Language Models

Lopez-Garcia, G.; Xu, D.; Luu, M.; Zheng, R.; Daskivich, T. J.; Gonzalez-Hernandez, G.

2025-08-11 oncology
10.1101/2025.08.07.25333034
Show abstract

Effective risk communication is essential to shared decision-making in prostate cancer care. However, the quality of physician communication of key tradeoffs varies widely in real-world consultations. Manual evaluation of communication is labor-intensive and not scalable. We present a structured, rubric-based framework that uses large language models (LLMs) to automatically score the quality of risk communication in prostate cancer consultations. Using transcripts from 20 clinical visits, we curated and annotated 487 physician-spoken sentences that referenced five decision-making domains: cancer prognosis, life expectancy, and three treatment side effects (erectile dysfunction, incontinence, and irritative urinary symptoms). Each sentence was assigned a score from 0 to 5 based on the precision and patient-specificity of communicated risk, using a validated scoring rubric. We modeled this task as five multiclass classification problems and evaluated both fine-tuned transformer baselines and GPT-4o with rubric-based and chain-of-thought (CoT) prompting. Our best performing approach, which combined rubric-based CoT prompting with few-shot learning, achieved micro averaged F1 scores between 85.0 and 92.0 across domains, outperforming supervised baselines and matching inter-annotator agreement. These findings establish a scalable foundation for AI-driven evaluation of physician-patient communication in oncology and beyond.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
JCO Clinical Cancer Informatics
based on 14 papers
Top 0.1%
16.3%
2
Scientific Reports
based on 701 papers
Top 6%
13.8%
3
PLOS ONE
based on 1737 papers
Top 61%
6.8%
4
Nature Communications
based on 483 papers
Top 12%
6.8%
5
PLOS Computational Biology
based on 141 papers
Top 3%
5.4%
6
npj Digital Medicine
based on 85 papers
Top 4%
4.8%
50% of probability mass above
7
npj Precision Oncology
based on 14 papers
Top 0.4%
4.8%
8
Nature Medicine
based on 88 papers
Top 3%
2.7%
9
International Journal of Radiation Oncology*Biology*Physics
based on 13 papers
Top 1%
2.6%
10
eLife
based on 262 papers
Top 10%
2.6%
11
Computers in Biology and Medicine
based on 39 papers
Top 4%
1.4%
12
Cancer Medicine
based on 17 papers
Top 3%
1.4%
13
JCO Precision Oncology
based on 11 papers
Top 2%
1.4%
14
JAMA Network Open
based on 125 papers
Top 12%
1.4%
15
Clinical Cancer Research
based on 22 papers
Top 3%
1.4%
16
Cancers
based on 57 papers
Top 6%
1.3%
17
iScience
based on 74 papers
Top 6%
0.8%
18
Frontiers in Oncology
based on 34 papers
Top 5%
0.8%
19
Cancer Epidemiology, Biomarkers & Prevention
based on 14 papers
Top 3%
0.8%
20
Radiotherapy and Oncology
based on 11 papers
Top 2%
0.7%
21
British Journal of Cancer
based on 22 papers
Top 4%
0.7%
22
Journal of the American Medical Informatics Association
based on 53 papers
Top 7%
0.7%
23
Bulletin of Mathematical Biology
based on 17 papers
Top 2%
0.7%
24
JAMIA Open
based on 35 papers
Top 6%
0.7%
25
Cureus
based on 64 papers
Top 18%
0.7%
26
Nature Genetics
based on 72 papers
Top 9%
0.7%